Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Current Deferred Revenue (2020 - 2026)

Definitive Healthcare filings provide 6 years of Current Deferred Revenue readings, the most recent being $97.0 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 3.9% to $97.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $97.0 million, a 3.9% increase, with the full-year FY2025 number at $97.0 million, up 3.9% from a year prior.
  • Current Deferred Revenue hit $97.0 million in Q4 2025 for Definitive Healthcare, up from $92.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $109.7 million in Q1 2025 to a low of $3.4 million in Q1 2022.
  • Median Current Deferred Revenue over the past 5 years was $95.2 million (2024), compared with a mean of $89.1 million.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 2998.88% in 2023 and later fell 4.14% in 2024.
  • Definitive Healthcare's Current Deferred Revenue stood at $84.0 million in 2021, then grew by 18.65% to $99.7 million in 2022, then decreased by 2.32% to $97.4 million in 2023, then fell by 4.14% to $93.3 million in 2024, then increased by 3.9% to $97.0 million in 2025.
  • The last three reported values for Current Deferred Revenue were $97.0 million (Q4 2025), $92.0 million (Q3 2025), and $100.9 million (Q2 2025) per Business Quant data.